With the drug going off-patent in India on March 20 this year, over 30 companies entered the market with cheaper alternatives and Novo Nordisk too reduced the prices of Ozempic and Wegovy by 36 percent and 48 percent respectively to Rs 1,415 per month from Rs 2,200 per month for a 0.25 mg per week for both
This means that roughly 2 - 3% of the population in the United States may now be taking one of these drugs
While validation in an independent cohort is required, the PREDICT study has potentially identified genetic markers that may have clinical utility in predicting early IGF-I generation and that could contribute to individualization of r-hGH dosing
September 4, 2025: Texas AG Files Lawsuit Against Eli Lilly for Zepbound Prescribing Practices The Attorney General of Texas has sued Zepbound manufacturer Eli Lilly, accusing the company of using illegal practices to boost sales
Polymorphisms in genes associated with collagen synthesis, muscle repair, and inflammation can influence an individuals susceptibility to ACL injuries
The typeface mirrors this concept with its utilitarian, functional glyphs